精神类药物在 COVID-19 大流行期间新处方数量下降。
Decline In New Starts Of Psychotropic Medications During The COVID-19 Pandemic.
机构信息
Ian Nason (
Dorit T. Stein is an incoming PhD student in the Department of Global Health and Population, Harvard T. H. Chan School of Public Health,in Boston, Massachusetts.
出版信息
Health Aff (Millwood). 2021 Jun;40(6):904-909. doi: 10.1377/hlthaff.2021.00028.
COVID-19 interrupted delivery of mental health care in the US. During the initial course of the COVID-19 pandemic new starts of antidepressants declined by 7.5 percent, anxiolytics by 5.6 percent, and antipsychotics by 2.6 percent compared with expected levels. Our findings suggest that there is large unmet need for mental health treatment in the US due to COVID-19.
COVID-19 中断了美国的精神卫生保健服务。在 COVID-19 大流行的初始阶段，与预期水平相比，抗抑郁药的新处方减少了 7.5%，抗焦虑药减少了 5.6%，抗精神病药减少了 2.6%。我们的研究结果表明，由于 COVID-19，美国有大量未满足的精神卫生治疗需求。
Zotero 插件